AXGN Trading Analysis - 10/19/2026 01:46 PM — TRU-SENTIMENT

AXGN (Axogen Inc. Common Stock) at $34.59. True Sentiment Bearish, delta 40-60 call 12% / put 88%, call $4,390 vs put $31,240. RSI 12.4.

TRU-SENTIMENT · DeltaNeutral

AXGN Trading Analysis - 10/19/2026 01:46 PM — TRU-SENTIMENT

Options chain · Stock chart · Baseline chart

AXGN (Axogen Inc. Common Stock) at $34.59. True Sentiment Bearish, delta 40-60 call 12% / put 88%, call $4,390 vs put $31,240. RSI 12.4.

Symbol
AXGN
Price
$34.59
Article bias (separate from True Sentiment)
bearish
Conviction
medium
Published
2026-10-19 13:46:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options)

From 2026-10-19 options flow (Delta 40-60 only):

Call Volume: $4,390 (12.3%) Put Volume: $31,240 (87.7%) Total: $35,630

  • Sentiment: Bearish (87.7% put dollar vol).
  • Contracts: 9 calls vs 38 puts; only 4 of 90 options analyzed met filter (4.4% pure conviction).
  • Read: Strong directional put conviction near-term; aligns with price below SMAs and RSI oversold-but-falling.
  • Divergence: Option spread engine flagged "Divergence detected between technical indicators and options sentiment" — technically oversold (RSI 12) yet sentiment bearish; no clear directional tech signal per engine.
Note: Options flow shows heavy put buying at Delta 40-60 range, confirmed bearish via tru-sentiment filter.

Key Statistics: AXGN

$34.59 +0.30%
52-Week Range
$16.23 - $52.91
Market Cap
$2.03B
P/E (TTM)
N/A
PEG Ratio
N/A
Beta
1.90
Next Earnings
N/A
Avg Volume
$960,823
Dividend Yield
0.00%

Fundamental Snapshot

Valuation

EPS (trailing 12 mo)$-0.66
Market cap$2.03B
Shares outstanding58.7M

Dividend

Dividend yield0.00%
Ex-dividend date2010-01-27

Risk & range

Beta1.90
52-week low$16.23
52-week high$52.91
Historical volatility51.7%

Ownership & trading

Institutional ownership55.9%
Average daily volume1.5M sh

Reported figures; no analyst estimates.


📈 Analysis

News Headlines & Context

Based on general knowledge of Axogen (AXGN), a regenerative medicine company focused on peripheral nerve repair, recent relevant context includes:

  • AXGN has historically been impacted by hospital procedure volumes; late 2026 recovery in elective surgeries may support revenue, though no specific recent earnings date is confirmed in provided data.
  • Previous commentary from 2025 indicated continued net losses as the company scaled commercial operations; negative EPS trajectory aligns with fundamentals shown.
  • Potential Medicare reimbursement changes for nerve grafts have been a recurring catalyst watched by investors in the regenerative med space.
  • No specific near-term binary event (e.g., FDA decision) is known from provided data, but high beta (1.90) suggests sensitivity to broader biotech sentiment.
  • Context: Heavy put positioning in options (87.7% put dollar vol) may reflect defensive positioning amid soft price trends, not necessarily a new fundamental negative.

Fundamental Analysis

From embedded FUNDAMENTALS data (2026-10-19):

  • Trailing EPS: -0.66 (company unprofitable, no positive earnings).
  • Trailing P/E: null; Forward P/E: null; PEG: null — standard valuation ratios not available due to negative earnings.
  • Market Cap: $2,029,464,480; Shares Out: 58,672,000; Institutional Ownership: 55.91%.
  • Dividend Yield: 0.00% (no income).
  • 52-Week High: $52.91; 52-Week Low: $16.24 — current price ~34.49 near lower half of range.
  • Beta: 1.90 (high volatility vs market).
  • Historical Volatility: 51.73%.
  • Revenue Growth, Margins, ROE, Debt/Equity, FCF: null in data (not disclosed in feed).
  • Analyst Target / Consensus: null (no recommendation key or mean target provided).

Fundamentals show a loss-making small-cap med device name with no standard valuation anchor. This diverges from any bullish technical setup since price is below all SMAs and sentiment is bearish.

Current Market Position

Current price per indicators: $34.49 (2026-10-16 close). Minute bars show 2026-10-19 13:15 last close $34.59, drifting from $35.40 at 2026-10-16 09:30 open. Intraday 10-19 range $34.53–$34.59 in final bars, low momentum.

Daily history: 30-day high $48.38 (2026-09-04), low $34.40 (2026-10-16). Price sits at bottom of 30-day range.

Support
$34.40
Resistance
$35.72
20d SMA
$39.33
50d SMA
$44.43
Lower BB
$31.92

Technical Analysis

Technical Indicators

RSI (14)
12.44
MACD
-2.62 / -2.09
50-day SMA
$44.43
20-day SMA
$39.33
5-day SMA
$35.72
ATR (14)
1.57
  • SMA alignment: Price $34.49 < SMA5 $35.72 < SMA20 $39.33 < SMA50 $44.43 — full bearish stack, no bullish crossovers.
  • RSI 12.44: deeply oversold, bearish momentum extreme.
  • MACD: -2.62 below signal -2.09, histogram -0.52 (negative, bearish).
  • Bollinger: Mid $39.33, Upper $46.75, Lower $31.92 — price below lower band extension, weak.
  • 30-day range: price at $34.49, just above low $34.40 (bottom 2% of range).

True Sentiment Analysis (Delta 40-60 Options)

From 2026-10-19 options flow (Delta 40-60 only):

Call Volume: $4,390 (12.3%) Put Volume: $31,240 (87.7%) Total: $35,630

  • Sentiment: Bearish (87.7% put dollar vol).
  • Contracts: 9 calls vs 38 puts; only 4 of 90 options analyzed met filter (4.4% pure conviction).
  • Read: Strong directional put conviction near-term; aligns with price below SMAs and RSI oversold-but-falling.
  • Divergence: Option spread engine flagged "Divergence detected between technical indicators and options sentiment" — technically oversold (RSI 12) yet sentiment bearish; no clear directional tech signal per engine.
Note: Options flow shows heavy put buying at Delta 40-60 range, confirmed bearish via tru-sentiment filter.

Key Price Levels (Observational Only)

Support (30d low)
$34.40
Lower BB
$31.92
SMA5
$35.72
SMA20
$39.33
SMA50
$44.43

Interactive charts load with JavaScript. This text is the crawlable summary.